Toxicology

Ophthalmic Pharmacology and In Vivo Studies

Call us at 408.738.9260

Comparative Biosciences, Inc. (CBI), a premier ocular research CRO, provides a large variety of validated discovery preclinical ophthalmic research studies including efficacy, pharmacology, or in vivo indications. Our ophthalmologic models include macular degeneration, retinopathies, dry eye, glaucoma, and inflammation. CBI scientists are available to discuss these models in more detail. CBI is also willing to work with our sponsors to develop unique, customized models or GLP efficacy studies.

Validated efficacy ophthalmic studies available at CBI include:

Models of Angiogenesis and Macular Degeneration

Read more on angiogenesis models

Models of Inflammation

  • Melanin-antigen associated uveitis in rats
  • IRBP-antigen associated inflammation in rodents
  • LPS-Induced acute inflammation in rabbits and rodents
  • Ovalbumin-induced immune mediated inflammation in rabbits
  • F40 80-Induced acute inflammation in rabbits
  • Corneal infection

Read more on MAA-Induced Inflammation

Models of Glaucoma

  • Laser-induced episcleral cautery for glaucoma in rats
  • Chymotrypsin-induced glaucoma in rabbits

Read more about glaucoma

Models of Dry Eye

  • Concanavalin A-induced dry eye in rabbits
  • Botulinum-induced dry eye in mice
  • Scopolamine-induced dry eye in mice
  • Atropine-induced dry eye in rabbit and mice

Models of Corneal Injury and Healing

  • HeptanolHeptanol-induced corneal erosion in rabbits
  • Suture-induced inflammation in rodents
  • Corneal pocket neovascularization

Read more on corneal wound healing models

Other Ocular Diseases

  • MNU-induced retinitis pigmentosa

For more information, contact CBI